title: Prospects for scaling-up supervised injection facilities in Canada: the role of evidence in legal and political decision-making.
abstract: BACKGROUND
  North America's first supervised injection facility-Insite-opened in Vancouver in 2003 under a special federal legal exemption. Insite has faced significant political and legal opposition, which culminated in a recent Supreme Court of Canada ruling that ordered the federal Minister of Health to extend the facility's exemption and cited evidence that the facility is life-preserving and does not increase public disorder. Officials in several other cities have initiated or accelerated preparations for new facilities due to speculation that the ruling provides sufficient legal basis to expand supervised injection in Canada. However, a comprehensive assessment of the barriers and facilitators to supervised injection facility scale-up is lacking.
  
  
  METHODS
  This policy case study reviews a corpus of jurisprudence, legislation, scientific research and media texts to: describe the role of evidence in legal and political decision-making around Insite; analyze the implications of the Insite decision for new facilities; and discuss alternative avenues for supervised injection facility expansion.
  
  
  RESULTS
  The Insite decision does not simplify the path towards new supervised injection facilities, but nor does it does pose an insurmountable hurdle. Whether new facilities will be established depends largely upon how the Minister of Health interprets the ruling, the proponents' ability to demonstrate need and support from municipal and provincial governments and community members. Formally defining supervised injection as within nurses' scope of practice could further efforts to establish new facilities.
  
  
  CONCLUSIONS
  Additional court action may be required to establish a stable legal and policy basis for supervised injection facilities in Canada.
authors.affiliation: Addiction and Mental Health Research Laboratory, School of Public Health, University of Alberta, Edmonton, AB, Canada. elaine.hyshka@ualberta.ca
authors.forename: Elaine
authors.initials: E
authors.lastname: Hyshka
authors.forename: Tania
authors.initials: T
authors.lastname: Bubela
authors.forename: T Cameron
authors.initials: TC
authors.lastname: Wild
mesh_terms: D001955:British Columbia; D003657:Decision Making; D019317:Evidence-Based Medicine; D040261:Harm Reduction; D006801:Humans; D018671:Needle-Exchange Programs / Q000331:legislation & jurisprudence / Q000600:supply & distribution*; D015819:Substance Abuse, Intravenous / Q000534:rehabilitation*